Tyra Biosciences (TYRA) Free Cash Flow (2020 - 2026)
Quarterly Free Cash Flow fell 27.95% to -$32.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$102.3 million through Mar 2026, down 40.02% year-over-year, with the annual reading at -$95.2 million for FY2025, 36.45% down from the prior year.
Tyra Biosciences filings provide 7 years of Free Cash Flow readings, the most recent being -$32.6 million for Q1 2026.
- Free Cash Flow hit -$32.6 million in Q1 2026 for Tyra Biosciences, down from -$23.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$9.2 million in Q1 2022 and bottomed at -$32.6 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$17.5 million, with a median of -$17.2 million recorded in 2023.
- The largest annual shift saw Free Cash Flow plummeted 274.6% in 2022 before it skyrocketed 43.05% in 2023.
- Tyra Biosciences' Free Cash Flow stood at -$12.0 million in 2022, then decreased by 12.69% to -$13.5 million in 2023, then plummeted by 40.34% to -$18.9 million in 2024, then fell by 25.01% to -$23.7 million in 2025, then plummeted by 37.71% to -$32.6 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Free Cash Flow are -$32.6 million (Q1 2026), -$23.7 million (Q4 2025), and -$22.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | -32.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.59 Mn |
| Mar 31, 2026 | -32.59 Mn |
| Dec 31, 2025 | -23.67 Mn |
| Dec 31, 2025 | -23.67 Mn |
| Sep 30, 2025 | -22.36 Mn |
| Sep 30, 2025 | -22.36 Mn |
| Jun 30, 2025 | -23.71 Mn |
| Jun 30, 2025 | -23.71 Mn |
| Mar 31, 2025 | -25.47 Mn |
| Mar 31, 2025 | -25.47 Mn |
| Dec 31, 2024 | -18.93 Mn |
| Dec 31, 2024 | -18.93 Mn |
| Sep 30, 2024 | -17.95 Mn |
| Sep 30, 2024 | -17.95 Mn |
| Jun 30, 2024 | -10.73 Mn |
| Jun 30, 2024 | -10.73 Mn |
| Mar 31, 2024 | -22.16 Mn |
| Mar 31, 2024 | -22.16 Mn |
| Dec 31, 2023 | -13.49 Mn |
| Dec 31, 2023 | -13.49 Mn |
| Sep 30, 2023 | -17.23 Mn |
| Sep 30, 2023 | -17.23 Mn |
| Jun 30, 2023 | -9.66 Mn |
| Jun 30, 2023 | -9.66 Mn |
| Mar 31, 2023 | -9.89 Mn |
| Mar 31, 2023 | -9.89 Mn |
| Dec 31, 2022 | -11.97 Mn |
| Dec 31, 2022 | -11.97 Mn |
| Sep 30, 2022 | -12.19 Mn |
| Sep 30, 2022 | -12.19 Mn |
| Jun 30, 2022 | -16.96 Mn |
| Jun 30, 2022 | -16.96 Mn |
| Mar 31, 2022 | -9.16 Mn |
| Mar 31, 2022 | -9.16 Mn |
| Dec 31, 2021 | -9.67 Mn |
| Dec 31, 2021 | -9.67 Mn |
| Sep 30, 2021 | -5.47 Mn |
| Sep 30, 2021 | -5.47 Mn |
| Jun 30, 2021 | -4.53 Mn |
| Jun 30, 2021 | -4.53 Mn |
| Mar 31, 2021 | -4.74 Mn |
| Mar 31, 2021 | -4.74 Mn |
| Dec 31, 2020 | -2.29 Mn |
| Dec 31, 2020 | -2.29 Mn |